Erratum: Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy (The FASEB Journal 27 (4691-4702) (DOI 10.1096/fj.13-229351));Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy

FASEB Journal

Volumn 27, Issue 12, 2013, Pages 4691-4702

  Vasconcelos, Juliana F ^a,b   Souza, Bruno S F ^a,b   Lins, Thayse F S ^a   Garcia, Letícia M S ^b   Kaneto, Carla M ^b,c   Sampaio, Geraldo P ^b   De Alcantara, Adriano C ^b   Meira, Cássio S ^a   Macambira, Simone G ^a,b,d   Ribeiro dos Santos, Ricardo ^b   Soares, Milena B P ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HOSPITAL SÃO RAFAEL   (Brazil)

^c DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Cytokine therapy; Fibrosis; Inflammation; Th1 modulation; Words: Trypanosoma cruzi

Indexed keywords

CD3 ANTIGEN; GALECTIN 3; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SYNDECAN 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE FIBROSIS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; TRYPANOSOMA CRUZI;

MEIRA; MUS; TRYPANOSOMA CRUZI;

EID: 84890446782     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-249813ERR     Document Type: Erratum

References (55)

1. Franco-Paredes, C., Von, A., Hidron, A., Rodríguez-Morales, A. J., Tellez, I., Barragán, M., Jones, D., Náquira, C. G., and Mendez, J. (2007) Chagas disease: an impediment in achieving the millennium development goals in Latin America. BMC Int. Health Hum. Rights 7, 1-6
2. Hotez, P. J., Bottazzi, M. E., Franco-Paredes, C., Ault, S. K., and Roses-Periago, M. (2008) The neglected tropical diseases of Latin America and the Caribbean: estimated disease burden and distribution and a roadmap for control and elimination. PLoS Negl. Trop. Dis. 2, 1-11
3. Franco-Paredes, C., Bottazzi, M. E., and Hotez, P. J. (2009) The unfinished public health agenda of Chagas disease in the era of globalization. PLoS Negl. Trop. Dis. 3, 1-4
4. World Health Organization. Chagas disease. Retrieved November 1, 2012, from http://www.who.int/mediacentre/factsheets/fs340/en/index.html
5. Bocchi, E. A., Bellotti, G., Mocelin, A., Uip, D., Bacal, F., Higuchi, M. L., Amato-Neto, V., Fiorelli, A., Stolf, N. A., Jatene, A. D., and Pileggi, F. (1996) Heart transplantation for chronic Chagas' heart disease. Ann. Thorac. Surg. 61, 1727-1733
6. Von-Aulock, S., Boneberg, E. M., Diterich, I., and Hartung, T. (2004) Granulocyte colony-stimulating factor (filgrastim) treatment primes for increased ex vivo inducible prostanoid release. J. Pharmacol. Exp. Ther. 308, 754-759
7. Hartung, T., Docke, W. D., Gantner, F., Krieger, G., Sauer, A., Stevens, P., Volk, H. D., and Wendel, A. (1995) Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85, 2482-2489
8. Boneberg E. M., and Hartung, T. (2002) Molecular aspects of anti-inflammatory action of G-CSF. Inflamm. Res. 51, 119-128
9. Iwanaga, K., Takano, H., Ohtsuka, M., Hasegawa, H., Zou, Y., Qin, Y., Odaka, K., Hiroshima, K., Tadokoro, H., and Komuro, I. (2004) Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem. Biophys. Res. Commun. 325, 1353-1359
10. Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., Matsuura, K., Sano, M., Nishi, J., Iwanaga, K., Akazawa, H., Kunieda, T., Zhu, W., Hasegawa, H., Kunisada, K., Nagai, T., Nakaya, H., Yamauchi-Takihara, K., and Komuro, I. (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11, 305-311
11. Higuchi, T., Yamauchi-Takihara, K., Matsumiya, G., Fukushima, N., Ichikawa, H., Kuratani, T., Maehata, Y., and Sawa, Y. (2008) Granulocyte colony-stimulating factor prevents reperfusion injury after heart preservation. Ann. Thorac. Surg. 85, 1367-1373
12. Rutella, S., Zavala, F., Danese, S., Kared, H., and Leone, G. (2005) Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J. Immunol. 175, 7085-7091
13. Sakaguchi, S. (2005) Naturally arising Foxp3-expressing CD25-CD4-regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352
14. Rutella, S., Pierelli, L., Bonanno, G., Sica, S., Ameglio, F., Capoluongo, E., Mariotti, A., Scambia, G., d'Onofrio, G., and Leone, G. (2002) Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 100, 2562-2571
15. Rossetti, M., Gregori, S., and Roncarolo, M. G. (2010) Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naive T cells. Eur. J. Immunol. 40, 3097-3106
16. Macambira, S. G., Vasconcelos, J. F., Costa, C. R., Klein, W., Lima, R. S., Guimarães, P., Vidal, D. T., Mendez, L. C., Ribeiro-Dos-Santos, R., and Soares, M. B. (2009) Granulocyte colonystimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function. FASEB J. 23, 3843-3850
17. Federici, E. E., Abelmann, W. H., and Neva, F. A. (1964) Chronic and progressive myocarditis and myositis in C3H mice infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 13, 272-280
18. Schijman, A. G., Bisio, M., Orellana, L., Sued, M., Duffy, T., Mejia Jaramillo, A. M., Cura, C., Auter, F., Veron, V., Qvarnstrom, Y., Deborggraeve, S., Hijar, G., Zulantay, I., Lucero, R. H., Velazquez, E., Tellez, T., Sanchez Leon, Z., Galvão, L., Nolder, D., Monje Rumi, M., Levi, J. E., Ramirez, J. D., Zorrilla, P., Flores, M., Jercic, M. I., Crisante, G., Añez, N., De Castro, A. M., Gonzalez, C. I., Acosta Viana, K., Yachelini, P., Torrico, F., Robello, C., Diosque, P., Triana Chavez, O., Aznar, C., Russomando, G., Büscher, P., Assal, A., Guhl, F., Sosa Estani, S., DaSilva, A., Britto, C., Luquetti, A., and Ladzins, J. (2011) International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl. Trop. Dis. 5, 1-13
19. Soares, M. B., de Lima, R. S., Rocha, L. L., Vasconcelos, J. F., Rogatto, S. R., dos Santos, R. R., Iacobas, S., Goldenberg, R. C., Iacobas, D. A., Tanowitz, H. B., de Carvalho, A. C., and Spray, D. C. (2010) Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. J. Infect. Dis. 202, 416-426
20. Gomes, J. A., Bahia-Oliveira, L. M., Rocha, M. O., Martins-Filho, O. A., Gazzinelli, G., and Correa-Oliveira, R. (2003) Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 71, 1185-1193
21. Köberle, F. (1968) Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 6, 63-116
22. Soares, M.B., Silva-Mota, K.N., Lima, R.S., Bellintani, M.C., Pontes-De-Carvalho, L., and Ribeiro-dos-Santos, R. (2001) Modulation of chagasic cardiomyopathy by IL-4: dissociation between inflammatory and tissue parasitism. Am. J. Pathol. 159, 703-709
23. Soares, M. B. P., Pontes-De-Carvalho, L., and Ribeiro-dos-Santos, R. (2001) The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An. Acad. Bras. Cienc. 73, 547-559
24. Bahia-Oliveira, L. M. G., Gomes, J. A. S., Rocha, M. O. S., Moreira, M. C., Lemos, E. M., Luz, Z. M., Pereira, M. E., Coffman, R. L., Dias, J. C., Cançado, J. R., Gazzinelli, G., and Corrêa-Oliveira, R. (1998) IFN-in human Chagas' disease: protection or pathology? Braz. J. Med. Biol. Res. 31, 127-131
25. Galhardo, M. C. G., Martins, I. A., Hasslocher-Moreno, A., Xavier, S. S., Coelho, J. M., Junqueira, A. C., and dos Santos, R. R. (1999) Reactivation of Trypanosoma cruzi infection in a patient with acquired immunodeficiency syndrome. Rev. Soc. Bras. Med. Trop. 32, 291-294
26. Campos, S. V., Strabelli, T. M., Amato Neto, V., Silva, C. P., Bacal, F., Bocchi, E. A., and Stolf, N. A. (2008) Risk factors for Chagas' disease reactivation after heart transplantation. J. Heart Lung Transplant. 27, 597-602
27. Tadokoro, C. E., and Abrahamsohn, I. A. (2001) Bone marrowderived macrophages grown in GM-CSF or M-CSF differ in their ability to produce IL-12 and to induce IFN-production after stimulation with Trypanosoma cruzi antigens. Immunol. Lett. 77, 31-38
28. Ferrari, R. (1999) The role of TNF in cardiovascular disease. Pharmacol. Res. 40, 97-105
29. Soares, M. B., Lima, R. S., Souza, B. S. F., Vasconcelos, J. F., Rocha, L. L., Dos Santos, R. R., Iacobas, S., Goldenberg, R. C., Lisanti, M. P., Iacobas, D. A., Tanowitz, H. B., Spray, D. C., and Campos de Carvalho, A. C. (2011) Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells. Cell Cycle 10, 1448-1455
30. Sloand, E., Kim, S., Maciejewski, J., Van Rhee, F., Chaudhuri, A., Barrett, J., and Young, N. S. (2000) Pharmacologic doses of granulocyte colony stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 95, 2269-2274
31. Ledebur, H. C., and Parks, T. P. (1995) Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-B site and p65 homodimers. J. Biol. Chem. 270, 933-943
32. Horowitz, A., Tkachenko, E., and Simons, M. (2002) Fibroblast growth factor-specific modulation of cellular response by syndecan-4. J. Cell Biol. 157, 715-725
33. Ishiguro, K., Kojima, T., and Muramatsu, T. (2003) Syndecan-4 as a molecule involved in defense mechanisms. Glycoconj. J. 19, 315-318
34. Hamon, M., Mbemba, E., Charnaux, N., Slimani, H., Brule, S., Saffar, L., Vassy, R., Prost, C., Lievre, N., Starzec, A., and Gattegno, L. (2004) A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1). Glycobiology 14, 311-313
35. Zhang, Y., Pasparakis, M., Kollias, G., and Simons, M. (1999) Myocyte-dependent regulation of endothelial cell syndecan-4 expression. Role of TNF-Alpha. J. Biol. Chem. 274, 14786-14790
36. Angeli, F. S., Amabile, N., Shapiro, M., Mirsky, R., Bartlett, L., Zhang, Y., Virmani, R., Chatterjee, K., Boyle, A., Grossman, W., and Yeghiazarians, Y. (2010) Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction. Cardiovasc. Drugs Ther. 24, 409-420
37. Joo, H. G., Goedegebuure, P. S., Sadanaga, N., Nagoshi, M., and Von Bernstorff, W., and Eberlein, T. J. (2001) Expression and function of galectin-3, a-galactoside-binding protein in activated T lymphocytes. J. Leukoc. Biol. 69, 555-564
38. Sharma, U. C., Pokharel, S., Brakel, T. J. V., van Berlo, J. H., Cleutjens, J. P., Schroen, B., André, S., Crijns, H. J., Gabius, H. J., Maessen, J., and Pinto, Y. M. (2004) Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110, 3121-3128
39. Reifenberg, K., Lehr, H. A., Torzewski, M., Steige, G., Wiese, E., Küpper, I., Becker, C., Ott, S., Nusser, P., Yamamura, K., Rechtsteiner, G., Warger, T., Pautz, A., Kleinert, H., Schmidt, A., Pieske, B., Wenzel, P., Münzel, T., and Löhler, J. (2007) Interferon-induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am. J. Pathol. 171, 463-472
40. Rabinovich, G. A., Ramhorst, R. E., Rubinstein, N., Corigliano, A., Daroqui, M. C., Kier-Joffé, E.B., and Fainboim, L. (2002) Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-Apoptotic mechanisms. Cell Death Differ. 9, 661-670
41. Zou, L., Barnett, B., Safah, H., Larussa, V. F., Evdemon-Hogan, M., Mottram, P., Wei, S., David, O., Curiel, T. J., and Zou, W. (2004) Bone marrow is a reservoir for CD4-CD25-regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64, 8451-8455
42. Kared, H., Masson, A., Adle-Biassette, H., Bach, J. F., Chatenoud, L., and Zavala, F. (2005) Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4-CD25-regulatory T-cells. Diabetes 54, 78-84
43. Francis, J. N., Till, S. J., and Durham, S. R. (2003) Induction of IL-10-CD4-CD25-T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 111, 1255-1261
44. Gardner, L. M., Thien, F. C., Douglass, J. A., Rolland, J. M., and O'Hehir, R. E. (2004) Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4-CD25-interleukin-10-T cells expressing peripheral tissue trafficking markers. Clin. Exp. Allergy 34, 1209-1219
45. Urry, Z., Chambers, E. S., Xystrakis, E., Dimeloe, S., Richards, D. F., Gabryšová, L., Christensen, J., Gupta, A., Saglani, S., Bush, A., O'Garra, A., Brown, Z., and Hawrylowicz, C. M. (2012) The role of 1-,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3-And IL-10-CD4-T cells. Eur. J. Immunol. 42, 2697-2708
46. Morris, E. S., MacDonald, K. P., Rowe, V., Johnson, D. H., Banovic, T., Clouston, A. D., and Hill, G. R. (2004) Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 103, 3573-3581
47. Hill, G. R., Olver, S. D., Kuns, R. D., Varelias, A., Raffelt, N. C., Don, A. L., Markey, K. A., Wilson, Y. A., Smyth, M. J., Iwakura, Y., Tocker, J., Clouston, A. D., and Macdonald, K. P. (2010) Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma. Blood 116, 819-828
48. Belkaid, Y., Blank, R. B., and Suffia, I. (2006) Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol. Rev. 212, 287-300
49. Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., and Sakaguchi, S. (1999) Thymus and autoimmunity: production of CD25-CD4-naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317-5326
50. Shevach, E. M. (2009) Mechanisms of foxp3-T regulatory cell-mediated suppression. Immunity 30, 636-645
51. Rutella, S., Bonanno, G., Pierelli, L., Mariotti, A., Capoluongo, E., Contemi, A. M., Ameglio, F., Curti, A., De Ritis, D. G., Voso, M. T., Perillo, A., Mancuso, S., Scambia, G., Lemoli, R. M., and Leone, G. (2004) Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-. Eur. J. Immunol. 34, 1291-1302
52. Vitelli-Avelar, D. M., Sathler-Avelar, R., Dias, J. C. P., Pascoal, V. P., Teixeira-Carvalho, A., Lage, P. S., Elói-Santos, S. M., Corrêa-Oliveira, R., and Martins-Filho, O. A. (2005) Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3-CD16-CD56-natural killer T cells and CD4-CD25High regulatory T lymphocytes. Scand. J. Immunol. 62, 297-308
53. De-Araújo, F. F., Vitelli-Avelar, D. M., Teixeira-Carvalho, A., Antas, P. R., Assis Silva Gomes, J., Sathler-Avelar, R., Otávio Costa Rocha, M., Elói-Santos, S. M., Pinho, R. T., Correa-Oliveira, R., and Martins-Filho, O. A. (2011) Regulatory T cells phenotype in different clinical forms of Chagas' disease. PLoS Negl. Trop. Dis. 5, 1-8
54. Guedes, P. M., Gutierrez, F. R., Silva, G. K., Dellalibera-Joviliano, R., Rodrigues, G. J., Bendhack, L. M., Rassi, A.. Jr., Rassi, A., Schmidt, A., Maciel, B. C., Marin Neto, J. A., and Silva, J. S. (2012) Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease. PLoS Negl. Trop. Dis. 6, 1-11
55. Olivares-Fontt, E. O., de Baetselier, P., Heirman, C., Thielemans, K., Lucas, R., and Vray, B. (1998) Effects of granulocytemacrophage colony-stimulating factor and tumor necrosis factor alpha on Trypanosoma cruzi trypomastigotes. Infect. Immun. 66, 2722-2727